Le Lézard
Classified in: Health, Science and technology, Business
Subject: VEN

Visla Raises Funding to Accelerate AI In Diagnostics


SAN FRANCISCO, Oct. 30, 2018 /PRNewswire/ -- Visla Labs, an AI medical diagnostics platform for radiology announced today that it has raised a $3M seed round. The round was led by venture firm Lux Capital with strong support from former Twitter CEO and COO Dick Costolo and Adam Bain, as well as prominent healthcare experts and advisors.  Visla's initial applications leverage cutting edge AI in imaging for radiology, and will use the capital to grow its team, scale product features, attain regulatory approval and fuel expansion and growth.

Medical imaging and diagnostics can be incredibly complex and time consuming, resulting often in a high rate of inaccuracy. Driven by an aging global population, teleradiology firms and urgent care centers are increasingly supply constrained in meeting patient demands to deliver life-critical care. Visla's AI products aim to deliver expert diagnosis at significantly lower costs and faster turnaround times.

"Visla's one click install puts power in hands of practitioners, empowering the practitioner not feeding the bureaucratic beast of status quo healthcare IT,"  said Zavain Dar, Principal at Lux Capital, who joins Visla's board of directors. "We've seen a number of companies applying computer vision to various diagnostic modalities in healthcare over the last four years. Simply put, what the Visla team has done in only eight months is light years beyond what any other team has yet to accomplish -- crack the nut of technology, productization, and distribution in a very hairy industry."

Early previews of the Visla technology are currently covering millions of lives in more than 30 clinical settings across the US and Asia and Visla's AI engines have ingested and processed millions of live images. In one example with an existing partner, Visla enabled 50% fewer missed diseases while automating 80% of healthy diagnosis.

"Our aim is to focus on the user, using the fastest and nimblest iteration to help in an industry where there is real need and potential to make a difference," said Wei-En Tan, Ph.D., co-founder of Visla. "We've seen the fragmented nature of healthcare for both doctors and patients,  and we're passionate about the opportunity to reimagine the process of radiology, so that it is efficient and simple for doctors, and cost-effective for everyone."

Visla was founded in 2018 by Kevin Quennesson, Wei-En Tan and Alessandro Sabatelli, all serial entrepreneurs who met while studying and working at Stanford, Apple and Twitter. Within six months, the company has experienced accelerated adoption globally. The founders were most recently leaders in the tech and aerospace industries, and heads of AI and machine learning and AR/VR at Twitter.

About Visla

Founded in 2018 and headquartered in San Francisco, Visla has built the premier AI-platform for radiology and the healthcare industry. Visla is collaborating with major hospitals, industry veterans, and award winning physicians to re-invent the imaging experience with self-improving AI at its core. With its products, Visla seeks to enhance diagnosis accuracy and unlock the next generation of augmented radiology. Visla is backed by Lux Capital and other prominent investors.  

Media Contact:

Martha Clavell
[email protected]
305-824-7478

SOURCE Visla Labs


These press releases may also interest you

at 06:35
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024. "Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our...

at 06:35
Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024. "The launch of ZURZUVAE is off to...

at 06:30
Sage Veterinary Imaging (SVI) has welcomed Peter Selover to its team as president and chief operating officer. Selover had previously served as chief executive officer of Exubrion Therapeutics....

at 06:14
The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's...

at 06:09
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Personalized Nutrition Market ? (By Purchase Model (Subscription, One Time Purchase), By End-users (Direct Consumers, Wellness & Fitness Centers,...

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...



News published on and distributed by: